We are live on ! Find out more
CBST

CUBIST PHARMACEUTICALS INC
CBST

Delisted

CBST was delisted on the 21st of January, 2015.

Back to rankings

0 hedge funds and large institutions have $0 invested in CUBIST PHARMACEUTICALS INC in 2015 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 302 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 307 → 0 (-307)

100% less funds holding in top 10

Funds holding in top 10: 35 → 0 (-35)

100% less capital invested

Capital invested by funds: $8B → $0 (-$8B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 302

Holders
–
Holders Change
-307
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-35
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
302
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$625M
2
Vanguard Group
Vanguard Group
Pennsylvania
-$474M
3
BFA
BlackRock Fund Advisors
California
-$309M
4
State Street
State Street
Massachusetts
-$290M
5
HI
HBK Investments
Texas
-$287M
Name Holding Trade Value Shares
Change 		Change in
Stake
Millennium Management
26
Millennium Management
New York
– -$78.9M -783,465 Closed
GP
27
GLG Partners
United Kingdom
– -$77.3M -767,613 Closed
AQR Capital Management
28
AQR Capital Management
Connecticut
– -$76.5M -760,054 Closed
Bank of New York Mellon
29
Bank of New York Mellon
New York
– -$72.7M -722,031 Closed
GF
30
Gabelli Funds
New York
– -$65.6M -651,500 Closed
JP Morgan Chase
31
JP Morgan Chase
New York
– -$65M -646,260 Closed
WCMNY
32
Westchester Capital Management (New York)
New York
– -$65M -646,255 Closed
AIM
33
Allen Investment Management
New York
– -$61.4M -610,276 Closed
PRCM
34
Pine River Capital Management
Minnesota
– -$61M -605,937 Closed
Northern Trust
35
Northern Trust
Illinois
– -$60.9M -604,594 Closed
UOC
36
UBS O'Connor
Illinois
– -$59.7M -592,729 Closed
BlackRock
37
BlackRock
New York
– -$58.6M -582,621 Closed
EM
38
Elliott Management
New York
– -$54.3M -539,000 Closed
Norges Bank
39
Norges Bank
Norway
– -$52.8M -524,213 Closed
Barclays
40
Barclays
United Kingdom
– -$51.6M -516,050 Closed
Alyeska Investment Group
41
Alyeska Investment Group
Illinois
– -$47.5M -472,320 Closed
Morgan Stanley
42
Morgan Stanley
New York
– -$47.3M -470,146 Closed
CC
43
Carlson Capital
Texas
– -$46.6M -462,500 Closed
CC
44
Coastland Capital
California
– -$44.6M -443,604 Closed
TCA
45
Taconic Capital Advisors
New York
– -$40.3M -400,000 Closed
Geode Capital Management
46
Geode Capital Management
Massachusetts
– -$40M -397,170 Closed
Adage Capital Partners
47
Adage Capital Partners
Massachusetts
– -$39.8M -395,138 Closed
AAM
48
AMI Asset Management
California
– -$37.8M -375,283 Closed
CCMU
49
Cheyne Capital Management (UK)
United Kingdom
– -$37.6M -373,372 Closed
AIMCA
50
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
– -$37.2M -369,430 Closed
1
2
3 4 5

CBST Hedge Fund Activity: Q1 2015 in Review

0 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in CUBIST PHARMACEUTICALS INC (CBST) for Q1 2015, worth a combined $0 — down 100% from $8B a quarter earlier.

Sellers outnumbered buyers: 302 funds closed out of CBST and 0 opened new positions — a net loss of 302 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Fidelity Investments, exiting entirely with an estimated $625M sold.

  • 0 institutional investors held CUBIST PHARMACEUTICALS INC (CBST) as of Q1 2015, down from 307 in Q4 2014.
  • Funds reported $0 of CUBIST PHARMACEUTICALS INC stock for Q1 2015, down 100% quarter-over-quarter.
  • 0 funds opened new CUBIST PHARMACEUTICALS INC positions in Q1 2015 and 302 closed out, a net change of -302 holders.
  • The largest CUBIST PHARMACEUTICALS INC seller in Q1 2015 was Fidelity Investments, an estimated $625M sold.

Based on aggregated 13F filings for Q1 2015.